SCHEDULE: JPMorgan Discloses 8.1% Stake in Hims & Hers Health

JPMorgan Chase & Co. has reported a beneficial ownership of 8.1% in Hims & Hers Health, Inc.'s Class A common stock as of September 30, 2025.

Summary

• JPMorgan Chase & Co. beneficially owns 17,796,759 shares of Hims & Hers Health, Inc. Class A common stock.
• This represents an 8.1% stake in the company's Class A common stock.
• The filing was made under Rule 13d-1(b), indicating a passive institutional investment.
• JPMorgan Chase & Co. holds sole voting power over 16,040,252 shares and sole dispositive power over 17,760,085 shares.
• The shares are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
• The beneficial ownership is held through various subsidiaries including J.P. Morgan Trust Company of Delaware, J.P. Morgan Securities LLC, and JPMorgan Asset Management (UK) Limited.

Sentiment

Score: 7

Explanation: The disclosure of a significant passive stake by a major financial institution like JPMorgan Chase & Co. can be viewed positively, indicating institutional confidence or interest in Hims & Hers Health, Inc.

Positives

• Significant institutional investment by JPMorgan Chase & Co. indicates confidence or interest in Hims & Hers Health.
• The passive nature of the investment (Rule 13d-1(b)) suggests it is not an activist stake, reducing potential for disruptive corporate actions.

Future Outlook

NA

Industry Context

This filing indicates a significant institutional investor's stake in the telehealth and personal care industry, suggesting continued investor interest in companies like Hims & Hers Health, which operates in a growing sector focused on direct-to-consumer healthcare services.

Stakeholder Impact

• Shareholders: May view the significant institutional ownership as a positive signal, potentially increasing confidence in the stock.
• Company Management: Could see this as validation of their business strategy and market position.

Key Dates

Recommendation

This filing is a disclosure of beneficial ownership by a large institution, not an operational or financial performance report. While the institutional interest is a positive signal, it does not provide enough fundamental information to warrant a 'buy' or 'sell' recommendation. A 'hold' recommendation reflects the neutral-to-positive signal without implying a change in the company's underlying value based solely on this disclosure.

Keywords

Hims & Hers Health, JPMorgan Chase, beneficial ownership, SEC filing, 13G, institutional investment, Class A common stock, telehealth, healthcare